ConductScience.org, home

Paper7701344

E5531, a pure endotoxin antagonist of high potency.

Christ WJ and 9 others. Science, 1995. Cited by 245 papers, by iCite.

Cite this record

ConductScience Library. E5531, a pure endotoxin antagonist of high potency. Papers, record 7701344. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7701344

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
E5531, a pure endotoxin antagonist of high potency.
PubMed
Journal
Science
PubMed
Year
1995
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
245
iCite
Relative citation ratio, by iCite
6.07
iCite
Revised in PubMed
2019-06-18
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Christ WJW J
2Asano OO
3Robidoux ALA L
4Perez MM
5Wang YY
6Dubuc GRG R
7Gavin WEW E
8Hawkins LDL D
9McGuinness PDP D
10Mullarkey MAM A

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
EndotoxinsMajor topic
Lipid AMajor topic
Animals
BCG Vaccine
Cytokines
Drug Design
Escherichia coli Infections
Gram-Negative Bacteria
Humans
In Vitro Techniques
Lipopolysaccharides
Macrophages
Male
Mice
Mice, Inbred C57BL
Monocytes
Moxalactam
Nitric Oxide
Rhodobacter capsulatus
Tumor Necrosis Factor-alpha

Source PubMed

Download CSV of topics

Cited by77

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 245 citations.

PMIDTitleJournalYearIn PapersSource
42635416HMGB1-targeted anti-inflammatory rBox A gene therapy for viral airway infections and systemic inflammatory disease models.mBio2026https://conductscience.org/library/papers/42635416PubMed
40033742Preclinical development of the TLR4 antagonist FP12 as a drug lead targeting the HMGB1/MD-2/TLR4 axis in lethal influenza infection.Innate Immun2025https://conductscience.org/library/papers/40033742PubMed
38110468Analysis of oxidized glucosylceramide and its effects on altering gene expressions of inflammation induced by LPS in intestinal tract cell models.Sci Rep2023https://conductscience.org/library/papers/38110468PubMed
38033733Small molecule modulators of immune pattern recognition receptors.RSC Chem Biol2023https://conductscience.org/library/papers/38033733PubMed
35744687Genome Sequence and Characterization of a Xanthorhodopsin-Containing, Aerobic Anoxygenic Phototrophic Rhodobacter Species, Isolated from Mesophilic Conditions at Yellowstone National Park.Microorganisms2022https://conductscience.org/library/papers/35744687PubMed
34113349Rhodobacter azotoformans LPS (RAP99-LPS) Is a TLR4 Agonist That Inhibits Lung Metastasis and Enhances TLR3-Mediated Chemokine Expression.Front Immunol2021https://conductscience.org/library/papers/34113349PubMed
33376308Preventive Effect of Lactobacillus acidophilus XY27 on DSS-Induced Ulcerative Colitis in Mice.Drug Des Devel Ther2020https://conductscience.org/library/papers/33376308PubMed
33356849Lipid larceny: channelizing host lipids for establishing successful pathogenesis by bacteria.Virulence2021https://conductscience.org/library/papers/33356849PubMed
32425790Like Cures Like: Pharmacological Activity of Anti-Inflammatory Lipopolysaccharides From Gut Microbiome.Front Pharmacol2020https://conductscience.org/library/papers/32425790PubMed
31741857Inhibitive effect of TAK-242 on Tenon's capsule fibroblasts proliferation in rat eyes.Int J Ophthalmol2019https://conductscience.org/library/papers/31741857PubMed
30154796Bradyrhizobium Lipid A: Immunological Properties and Molecular Basis of Its Binding to the Myeloid Differentiation Protein-2/Toll-Like Receptor 4 Complex.Front Immunol2018https://conductscience.org/library/papers/30154796PubMed
29518316Dissecting the Innate Immune Recognition of Opioid Inactive Isomer (+)-Naltrexone Derived Toll-like Receptor 4 (TLR4) Antagonists.J Chem Inf Model2018https://conductscience.org/library/papers/29518316PubMed
28769820Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics.Front Physiol2017https://conductscience.org/library/papers/28769820PubMed
28621828Progress in the synthesis and biological evaluation of lipid A and its derivatives.Med Res Rev2018https://conductscience.org/library/papers/28621828PubMed
26995266Sepsis: in search of cure.Inflamm Res2016https://conductscience.org/library/papers/26995266PubMed
26798659Balancing Innate Immunity and Inflammatory State via Modulation of Neutrophil Function: A Novel Strategy to Fight Sepsis.J Immunol Res2015https://conductscience.org/library/papers/26798659PubMed
26771196In Search of a Cure for Sepsis: Taming the Monster in Critical Care Medicine.J Innate Immun2016https://conductscience.org/library/papers/26771196PubMed
26535075Lipid A as a Drug Target and Therapeutic Molecule.Biomol Ther (Seoul)2015https://conductscience.org/library/papers/26535075PubMed
25620999Novel drugs targeting Toll-like receptors for antiviral therapy.Future Virol2014https://conductscience.org/library/papers/25620999PubMed
25553892Characterization of TRIF selectivity in the AGP class of lipid A mimetics: role of secondary lipid chains.Bioorg Med Chem Lett2015https://conductscience.org/library/papers/25553892PubMed

See all 77 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7701344

GET https://conductscience.org/api/papers/v1/7701344/cited_by?page=2